Hot Pursuit     05-Mar-21
Shilpa Medicare gets USFDA nod for arthritis drug
Shilpa Medicare has received United States Food and Drug Administration (USFDA)'s tentative approval for its abbreviated new drug application (ANDA), apremilast tablets, 10 mg, 20 mg, and 30 mg.

The ANDA was filed as 'First to File' submission on NCE -1 date to seek eligibility for 180 days exclusivity.

Apremilast tablets, 10 mg, 20 mg, and 30 mg is a generic equivalent of reference listed drug (RLD) OTEZLA of Celgene, used in the treatment of 'psoriatic arthritis' as recommended in the label approved by FDA.

According to IQVIA MAT Q2 2020 data, the US market for apremilast tablets, 10 mg, 20 mg, and 30 mg is approximately US $2.4 billion.

Shilpa Medicare is a global brand in manufacturing and supplying of affordable API and formulation globally in different regulated markets.

The company's consolidated net profit dropped 86.07% to Rs 7.67 crore on a 19.25% fall in net sales to Rs 191.25 crore in Q3 FY21 over Q3 FY20.

The scrip fell 1% to currently trade at Rs 380.20 on the BSE.

Previous News
  Shilpa Medicare reports consolidated net profit of Rs 1.61 crore in the September 2023 quarter
 ( Results - Announcements 11-Nov-23   07:41 )
  Shilpa Medicare ties up with Cadila Healthcare for production of ZyCoV-D vaccine
 ( Hot Pursuit - 24-Sep-21   14:21 )
  Volumes jump at Shilpa Medicare Ltd counter
 ( Hot Pursuit - 21-Feb-23   14:30 )
  Shilpa Medicare launches anti-cancer drug - IBRUSHIL
 ( Corporate News - 28-May-20   11:27 )
  Cadila Healthcare signs agreement with Shilpa Biologicals for production of ZyCoV-D vaccine
 ( Corporate News - 24-Sep-21   17:10 )
  Shilpa Medicare Hyderabad unit clears USFDA inspection with zero observations
 ( Hot Pursuit - 25-Jun-24   14:18 )
  Clariant Chemicals (India) Ltd leads losers in 'A' group
 ( Hot Pursuit - 18-Feb-21   15:00 )
  Shilpa Medicare receives Import Alert for its Telangana facility
 ( Corporate News - 18-Feb-21   14:44 )
  Shilpa Medicare consolidated net profit rises 73.94% in the June 2017 quarter
 ( Results - Announcements 11-Aug-17   16:21 )
  Shilpa Medicare gains on bargain hunting
 ( Hot Pursuit - 28-Dec-16   15:02 )
  Shilpa Medicare schedules board meeting
 ( Corporate News - 02-Feb-18   12:22 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top